Stock Earnings
UBS analysts downgrades a Neutral rating for Coherus Oncology Inc (CHRS)
Coherus Oncology Inc’s recently made public that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23
Menu
Coherus Oncology Inc’s recently made public that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23
Coherus Oncology Inc’s filing revealed that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23 ’25.
Coherus Oncology Inc’s recently made public that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23
Coherus Oncology Inc’s recently made public that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or